b'MintzRxOur PBM & Pharmacy Team introduced a newsletter covering legal, regulatory, and industry developments across the pharmaceutical supply chain. The inaugural edition covers developments affecting prescription drug pricing, including provisions in the Inflation Reduction Act, how the Supreme Court decision in Dobbs v. Jackson Womens Health Organization impacts pharmacies, federal enforcement actions targeted at pharmacies, and more.VIEW THE NEWSLETTERSEIZING OPPORTUNITY:THE POST-PANDEMIC FUTURE OFUS LIFE SCIENCES M&A 2022In the third annual Mintz and Mergermarket report on M&A in the life sciences sector, we explore the peak levels of dealmaking across the industry in 2021, discuss the evolving market, and provide industry deal data from 2017 through Q1 2022. We also share the results of our survey of 100 US-based executives, including insights on how dealmaking is shaped by pandemic trends, the growing importance of partnerships, and emerging post-merger integration issues.VIEW THE REPORT6'